Dr. Natalie C. Yin, MD

Dr. Yin practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.

Dr. Yin's NPI, 1215340450, was assigned on June 5, 2014. Dr. Yin graduated from University of Miami, Lm Miller School of Medicine in 2014. Dr. Yin holds New York license 295403.

Dr. Yin's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.

Dr. Yin's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. Dr. Yin is also affiliated with Providence St. Vincent Medical Center. The medical group on file is Providence Medical Group, Oregon. Dmand AI also links Dr. Yin to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yin practices, 3 sites in all. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Yin's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dmand AI has Dr. Yin's licenses on file in 2 states: New York and Oregon.

CMS data shows 1,021 Medicare services from Dr. Yin across 12 procedure codes in 2024, for 165 Medicare patients. Medicare paid $46,092 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Yin in 2024. The largest group is 65 to 74, with 102 patients. 62% of them have high cholesterol, and 52% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yin's median patient age at 70, with 62% women.

In 2024, Dr. Yin wrote 367 Medicare Part D claims for 159 patients. 94% of them were for generic drugs. CMS names the drug for 237 of them, across 12 drugs with 11 or more claims each, at $6,019 in total drug cost. In 2023, CMS named 235 claims across 10 drugs.

Dr. Yin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 441 procedures of skin biopsy by Dr. Yin, more than 94% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Yin, published from 2011 to 2022. 2022 was the busiest year, with 4. The most frequent topics are Dermatitis, Atopic, Pyrimidines and Sulfonamides. Dr. Yin's most frequent co-authors are Hernan Valdez, MD, Clara Milikowski and Shailee B. Patel, MD.

CMS Open Payments shows 94 general payments to Dr. Yin from 17 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 50% of the total. Sanofi and Genzyme US Companies paid the most, $2,174. It also lists 4 research payments totaling $9,200 in 2022.

Dr. Yin graduated from University of Miami, Lm Miller School of Medicine in 2014.